# Phase II Study of NGC-Triple Regimen in Potentially Resectable Pancreatic Cancer Patients

> **NCT03392571** · PHASE2 · WITHDRAWN · sponsor: **Pancreatic Cancer Research Team**

## Conditions studied

- Resectable Pancreatic Cancer

## Interventions

- **DRUG:** NGC-Triple regimen

## Key facts

- **NCT ID:** NCT03392571
- **Lead sponsor:** Pancreatic Cancer Research Team
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2018-08-15
- **Primary completion:** 2020-12-30
- **Final completion:** 2020-12-30
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Study was stopped due to lack of funding
- **Last updated:** 2019-05-07

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03392571

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03392571, "Phase II Study of NGC-Triple Regimen in Potentially Resectable Pancreatic Cancer Patients". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT03392571. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*